Cure My Disease

Don't miss your cure!

 Log in / Sign up

Meal replacements tested as Low-Cost tool for weight and diabetes control

NCT ID NCT05799222

Recruiting now Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether meal replacement products can help low-income adults with obesity, prediabetes, or type 2 diabetes lose weight and lower blood sugar. Twenty participants will use meal replacements and be monitored for weight loss and blood sugar changes. The goal is to see if this approach is practical and effective for a population that often faces barriers to healthy eating.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Meal replacement products (Bariatrix)
What this could lead to
If successful, this could show that affordable meal replacement programs help low-income people manage weight and blood sugar, pointing toward a practical treatment option.
What could go wrong
This is a very small feasibility study with only 20 participants, so results may not apply broadly. Meal replacements may be hard to stick with long-term, and the study doesn't test for lasting effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 2 OBESITY OVERWEIGHT PREDIABETES

Contacts and locations

Locations

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.